インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

月刊カタログ配信中

再生医療情報サイト regenerative-medicine.jp - 再生医療市場情報

医療/バイオの調査資料販 MEDINFO.JP

幹細胞特集
幹細胞特集ページ 幹細胞関連の
レポートをご紹介いたします。

BioProcess International  Asia Pacific 公式サイト

BioLOGIC India 2008 公式サイト

Antibody Engineering 2008 公式サイト

PepTalk 2009 公式サイト

AsiaTIDES 公式サイト
English Korean
【 英文市場調査報告書 】

海洋バイオテクノロジーの世界市場

Marine Biotechnology

商品コード : 63824 Global Industry Analysts, Inc.
出版日 : 2008/03
発行 : Global Industry Analysts, Inc.
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications Analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the United States, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2012. The report profiles 87 companies including many key and niche players worldwide such as Aker BioMarine ASA, CP Kelco US, Inc., Cyanotech Corp., Elan Corp, FMC Corp., FMC Biopolymers AS, GlycoMar Ltd., Integrin Advanced Biosystems, International Specialty Products Inc., Lonza Group Ltd, MariCal, Marinova, Martek Biosciences Corp., Mera Pharmaceuticals Inc., New England Biolabs Inc., PharmaMar S.A, PML Applications Ltd., Primex Ltd., Prolume Ltd., Sea Run Holdings Inc., and Tequesta Marine Biosciences. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability And Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions And Scope Of Study
  • By Product Segment
  • Biomaterials
  • Bioactive Substances
  • Others
  • By End-Use Application
  • Industrial Products
  • Health Care/Biotechnology
  • Consumer Products
  • Public Services And Infrastructure
  • Others

II. EXECUTIVE SUMMARY

1. Industry Dynamics

  • Market Scorecard
  • Trends and Issues
  • Medical and Industrial Sectors Garner Research Dollars
  • Lack of R&D Investment in the Marine Biotech Industry
  • Preserving Marine Ecology: A Prime Concern

2. Marine Biotechnology - An Overview

  • A Curtain Raiser
  • Why are Microorganisms Crucial?
  • Brief History
  • Definition
  • Sources of Marine Biotech Products
  • Key Marine Sources and Products
  • Select Marine-Derived Products
  • Flora and Fauna
  • Protista
  • Bacteria
  • Fungi
  • Types of Marine Biotech Products
  • Marine Biomaterials
  • Marine Adhesives
  • Marine Bioactive Substances
  • Select Biological Materials and Chemicals Extracted from Marine Organisms
  • Select Companies Involved in Supplying Reagents or Nutritional Products from Marine Organisms
  • Enzymes
  • Haloperoxidase Enzymes
  • Thermostable DNA-Modifying Enzymes
  • Other Marine Products and Processes
  • Marine Biomass
  • Marine Bio-Process
  • Certain Significant Bio-Processes and their Application
  • End-Use Analysis
  • Definition
  • Overview
  • Application Areas
  • Foods
  • Nutraceuticals
  • Medicine
  • Cosmetics
  • Research Tools
  • Processing Technologies
  • New Energy Sources
  • Agriculture
  • Industrial
  • Food Safety
  • Environmental Management
  • Bioremediation
  • Marine Biosurfactants
  • Select Biosurfactants Produced from Marine Microorganisms
  • Aquaculture and Marine Biotechnology
  • Select Companies Carrying Out Genetic Enhancement or Aquaculture Breeding Programs
  • Industrial Applications
  • Healthcare
  • Select Therapeutic Compounds in the Pipeline
  • Select Marine Diterpenes and Their Biological Activity
  • Select Players Involved in Biosensor/Diagnostic Activity
  • Select Marine-Based Drugs
  • Cytosar-U
  • Prialt
  • Yondelis
  • Bryostatin
  • Didemnin B
  • Dehydrodidemnin B
  • Pseudopterosins
  • Bio-Prospecting
  • Select Companies Involved in Bioprospecting and Bioscreening for Novel Marine-Based Compounds
  • Consumer Products
  • Select Macroalgal Materials and Their Application in Cosmetic Industry
  • Public Services and Infrastructure
  • Others
  • Agriculture
  • Mining
  • An Insight into Select Marine-Origin Products
  • Agar
  • Major Seaweeds Used for Extracting Agar and Agarose
  • Alginate
  • Astaxanthin
  • Select Producers of Natural and Synthetic Astaxanthin
  • Carrageenan
  • Chitin and Chitosan
  • Chitin
  • End-use Applications
  • Chitosan
  • Select Industrial Applications of Chitosan
  • Collagen
  • Salmon Calcitonin
  • Research and Development Activity
  • Medical
  • Research on Natural Products
  • Tackling Biotoxins
  • Controlling Oil Spill Damage
  • Preventing Biofouling
  • Antifouling Coatings
  • Coral Reefs Offer Abundant Opportunities

3. Regional Market Overview

  • United States
  • Market Outlook
  • Overview
  • Aquaculture Biotechnology
  • Rest of World
  • Market Outlook
  • Australia
  • Canada
  • China
  • Europe
  • United Kingdom
  • Norway
  • Overview
  • Market Participants
  • Industrial Applications
  • Pharmaceuticals
  • Latin America
  • India
  • Marine Environment Offers Abundant Opportunities for R&D Initiatives
  • Market Participants
  • Government Initiatives
  • New Zealand

4. Recent Industry Activity

  • Aker BioMarine Merges with Natural ASA to Form Aker BioMarine
  • Aker BioMarine Joins Hands with Pronova Biocare
  • ABL Biotech to Establish New R&D Facility
  • Aquapharm Strikes an Agreement with DowpharmaSM
  • MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials for NPI-0052
  • CP Kelco Acquires Gold Millet
  • Oman’s Attempt To Excel in Marine Research
  • Marical Inks an Agreement with ACD
  • PharmaMar Conducts Clinical Testing of Zalypsis ® Anti-tumor Agent
  • Indore Biotech Inputs to Introduce Fungi-Based Biopesticides
  • CP Kelco Merges with Noviant
  • Marine Institute, Biotrove, and NUI’S Cooperative Research on Atlantic Salmon
  • Jinghua Marine Biological Merges with Work Recovery Inc
  • Albany Molecular Research and Alcon Research in Partnership
  • Maryland-Israel Marine Biotechnology Research Program Gains Extension
  • India to Set Up New National Institutions
  • European Centre for Marine Biotechnology Inaugurated
  • Diversa Collaborates with OSU
  • PharmaMar Commences Phase I Clinical Trials of PM02734
  • USFDA Confers Orphan Drug Status to PharmaMar’s Ovarian Cancer Drug, YONDELIS®
  • PharmaMar Undertakes Phase II Clinical Trials of Aplidin ® for Bladder and Prostate Cancers
  • CorMatrix and Cook Biotech Enter into Research Agreement
  • Elan Corp Receives European Approval for PRIALT™ (Ziconotide)

5. Focus on Select Players

  • Aker BioMarine ASA (Norway)
  • CP Kelco US, Inc. (USA)
  • Cyanotech Corp. (USA)
  • Elan Corp (Ireland)
  • FMC Corp. (USA)
  • FMC Biopolymers AS (Norway)
  • GlycoMar Ltd. (UK)
  • Integrin Advanced Biosystems (UK)
  • International Specialty Products Inc (USA)
  • Lonza Group Ltd (Switzerland)
  • MariCal (USA)
  • Marinova (Australia)
  • Martek Biosciences Corp. (USA)
  • Mera Pharmaceuticals Inc (USA)
  • New England Biolabs Inc (USA)
  • PharmaMar S.A (Spain)
  • PML Applications Ltd. (UK)
  • Primex Ltd (Iceland)
  • Prolume Ltd (USA)
  • Sea Run Holdings Inc (USA)
  • Tequesta Marine Biosciences (USA)

6. Global Market Perspective

  • Table 1: World Recent Past, Current & Future Analysis for Marine Biotechnology by Geographic Region- United States and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 2: World 10-Year Perspective for Marine Biotechnology by Geographic Region- Percentage Breakdown of Dollar Sales for United States and Rest of World Markets for Years 2003, 2007 & 2012
  • Table 3: World Recent Past, Current & Future Analysis for Marine Biotechnology by Product Segment- Marine Biomaterials, Marine Bioactive Substances, and Others Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 4: World 10-Year Perspective for Marine Biotechnology by Product Segment- Percentage Breakdown of Dollar Sales for Marine Biomaterials, Marine Bioactive Substances and Other Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)
  • Table 5: World Recent Past, Current & Future Analysis for Marine Biotechnology by End-use Application-Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Other Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart)
  • Table 6: World 10-Year Perspective for Marine Biotechnology by End-Use Application- Percentage Breakdown of Dollar Sales for Industrial Products, Health Care/ Biotechnology, Consumer Products, Public Services and Infrastructure and Other Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart)

ご注意:当報告書はDRM(デジタル著作権管理システム)付PDFとなります。 PDFのダウンロード・閲覧にはAdobe Acrobat Reader Ver. 7.0 が必要となります。ご購入頂いた場合、同Acrobat Reader (ご購入時無償配布)をPCにインストールして頂き、ダウンロードを行ったPC上のみでの閲覧と、1回のプリントアウトが可能となっております。ご不明な点につきましてはお問合せください。

概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
海洋バイオテクノロジーの世界市場
Marine Biotechnology
出版日 : 2008/03
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、銀行レート (TTS: 101.06) 換算による円建てのご請求書にて承ります。

US $ 3,950 換算 -> ¥ 399,187 (税抜) Hard Copy
US $ 3,950 換算 -> ¥ 399,187 (税抜) PDF by E-mail (Single User License)
商品コード : 63824
関連する商品をキーワードで検索する